Search Results

You searched for : LatestNewsonCOVIDTreatment  

	RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ... Jan 02
	The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ... Dec 17
	Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
	PureTech starts phase 2 trial of LYT-100 in long COVID-19 respiratory complications and related sequelae PureTech’s global, randomized, double-blind, placebo-controlled Phase 2 trial is designed to evaluate the efficacy, safety and tolerability of LYT-100 in adults ... Dec 05
	Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India Zydus Cadila, had received an approval from the Drugs Controller General of India to start the Phase 3 clinical trial in COVID-19 patients with ... Dec 04
	Roche receives USFDA emergency use authorization for new test to measure the level of SARS-CoV-2 antibodies This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19... Dec 03
	ARCA biopharma receives U.S. FDA fast track designation for AB201 as a potential treatment for COVID-19 ARCA believes that AB201 is the only anticoagulant class new chemical entity in development for COVID-19 that has a Fast Track designation... Nov 24
	RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
	AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19 Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
	Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
	India's indigenous solution to COVID-19 in progress Monoclonal antibody leads for COVID-19: A way forward In combating COVID-19 ... Nov 19
	Fluvoxamine an antidepressant drug may help prevent severe COVID-19 Researchers say, fluvoxamine may be having beneficial effects by some other mechanism not yet understood... Nov 17
	Eli Lilly's bamlanivimab receives US FDA clearance for the treatment of COVID-19 Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19... Nov 12
	Celltrion Launches CT-P59, an antibody preventive treatment for COVID-19 Celltrion launches post-exposure prophylaxis clinical trial of anti-COVID-19 monoclonal antibody treatment candidate, CT-P59 ... Oct 15
14 Matching result(s) found!

Trending Now
	Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
	Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
	A Practical Guide to Fibre: How Indian Adults Can Add More Without Digestive DiscomfortSeptember 12, 2026
	Understanding Heart Palpitations: Common Triggers, Helpful Records, and Warning SignsSeptember 12, 2026
	The Fourth Trimester: Why Healthcare Often Stops Too Early After DeliverySeptember 12, 2026
	Postpartum Mental Health: The Healthcare Gap Nobody Talks About EnoughSeptember 12, 2026
	Fortis Escorts Faridabad Launches Region’s First Dedicated ‘Fever Clinic’ for Early Diagnosis and Timely TreatmentSeptember 11, 2026
	Aksigen IVF Expands Science-led Fertility Care with New Integrated Centre in PanvelSeptember 11, 2026
	MGM Cancer Institute Marks World Rose Day with Milestone of 100 Bone Marrow Transplants and Launch of SwasthiSeptember 11, 2026
	Government of Rajasthan & Girl Effect India launch ‘Teeka Talk’ to increase HPV Vaccination Awareness Across the StateSeptember 11, 2026
	Healthy Snacks for Children: Smart Indian Alternatives to Highly Processed FoodsSeptember 11, 2026
	Understanding Constipation: Fibre, Fluids, Movement, and When Symptoms Need AttentionSeptember 11, 2026
	Medical Device Cybersecurity: When a Connected Device Becomes a Security RiskSeptember 11, 2026
	Zero-Trust Security for Hospitals: Why Traditional Network Security Is No Longer EnoughSeptember 11, 2026
	Understanding Vertigo: Why the Room Feels Like It Is Spinning and What to Do NextSeptember 10, 2026
	Healthy Eating on a Budget: Nutritious Indian Meals for FamiliesSeptember 10, 2026
	AI in Ultrasound: How Intelligent Imaging Could Transform Diagnostic Access in IndiaSeptember 10, 2026
	How AI Is Changing Pathology Laboratories in IndiaSeptember 10, 2026
	Healthy Breakfast Ideas for Busy Indian Professionals: Building a Balanced Morning PlateSeptember 09, 2026
	Understanding Seasonal Skin Dryness: Everyday Care for Indian Climates and Sensitive SkinSeptember 09, 2026